FDA’s Last Licks for 2016: Issues SIX (6) Enforcement Letters in December, So Far!
Click on image for enlarged view.
Just when you thought the FDA was finished issuing Warning and Untitled letters for 2016, it issued 2 more - both Untitled letters - last week,...
Images Tell the Story of Pharma in 2016
Yes, 2016 was a lousy year for many people and even for the drug industry, but for different reasons. I've already reviewed data from 2016 that document some good news for...
What’s Roche Doing on Pinterest?
What's Roche Doing on Pinterest?
What’s Boehringer Ingelheim Doing on Pinterest?
What's Boehringer Ingelheim Doing on Pinterest?
Top Pharma Companies on Pinterest
According to ad agency AbelsonTaylor (AT), Pinterest has "enormous potential for healthcare marketing. Healthcare marketers should be engaging the outstanding attributes of Pinterest in their digital, e-commerce and social media marketing...
FDA Cites TV Ads for “Compelling” “Attention-Grabbing” Distractions That Undermine Communication of Risks
According to an untitled letter FDA recently sent to Sanofi, all the fast-paced "grooving" going on in the “Mr. Groove” TV ad (here) for Toujeo makes it "difficult for consumers to...
Drugs for Older Americans Rose an Average of 15.5% in 2015 According to AARP...
Retail prices for brand name prescription drugs widely used by older Americans rose by an average of 15.5% in 2015—almost 130 times faster than the 0.1% general inflation rate—according to a...
Flowchart: How Pharma Can Handle Every Type of Comment on Social Media
With apologies to Health Care Social Media Blog.
Philippe Kirby (@PhilippeKirby), Pharma Customer Engagement Ecosystem designer & developer @ Merck & MSD, asked "Is this a joke?" I respect Philippe's opinion and...
2016 Year in Review: Charts & Graphs
I heard on Twitter that no one wants to see your "Year in Review." @lucyboyen, for example, tweeted "I looked at my year in review and thought to myself you know...
21st Century Cures for Pharmaceutical Marketing
In what Public Citizen described as an "Early Gift for the Pharmaceutical Industry" (see here), the Senate this week passed the 21st Century Cures Act (21st CC), which contains many provisions...
